-
Something wrong with this record ?
Infectious origin of Alzheimer's disease: Amyloid beta as a component of brain antimicrobial immunity
I. Vojtechova, T. Machacek, Z. Kristofikova, A. Stuchlik, T. Petrasek
Language English Country United States
Document type Journal Article, Review, Research Support, Non-U.S. Gov't
NLK
Directory of Open Access Journals
from 2005
Free Medical Journals
from 2005
Public Library of Science (PLoS)
from 2005
PubMed Central
from 2005
Europe PubMed Central
from 2005
ProQuest Central
from 2005-09-01
Open Access Digital Library
from 2005-01-01
Open Access Digital Library
from 2005-01-01
Open Access Digital Library
from 2005-09-01
Medline Complete (EBSCOhost)
from 2005-09-01
Health & Medicine (ProQuest)
from 2005-09-01
ROAD: Directory of Open Access Scholarly Resources
from 2005
- MeSH
- Alzheimer Disease * metabolism MeSH
- Amyloid beta-Peptides metabolism MeSH
- Amyloid beta-Protein Precursor metabolism MeSH
- Anti-Bacterial Agents therapeutic use MeSH
- Anti-Infective Agents * metabolism MeSH
- Humans MeSH
- Brain pathology MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
The amyloid cascade hypothesis, focusing on pathological proteins aggregation, has so far failed to uncover the root cause of Alzheimer's disease (AD), or to provide an effective therapy. This traditional paradigm essentially explains a mechanism involved in the development of sporadic AD rather than its cause. The failure of an overwhelming majority of clinical studies (99.6%) demonstrates that a breakthrough in therapy would be difficult if not impossible without understanding the etiology of AD. It becomes more and more apparent that the AD pathology might originate from brain infection. In this review, we discuss a potential role of bacteria, viruses, fungi, and eukaryotic parasites as triggers of AD pathology. We show evidence from the current literature that amyloid beta, traditionally viewed as pathological, actually acts as an antimicrobial peptide, protecting the brain against pathogens. However, in case of a prolonged or excessive activation of a senescent immune system, amyloid beta accumulation and aggregation becomes damaging and supports runaway neurodegenerative processes in AD. This is paralleled by the recent study by Alam and colleagues (2022) who showed that alpha-synuclein, the protein accumulating in synucleinopathies, also plays a critical physiological role in immune reactions and inflammation, showing an unforeseen link between the 2 unrelated classes of neurodegenerative disorders. The multiplication of the amyloid precursor protein gene, recently described by Lee and collegues (2018), and possible reactivation of human endogenous retroviruses by pathogens fits well into the same picture. We discuss these new findings from the viewpoint of the infection hypothesis of AD and offer suggestions for future research.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22032640
- 003
- CZ-PrNML
- 005
- 20230131151247.0
- 007
- ta
- 008
- 230120s2022 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1371/journal.ppat.1010929 $2 doi
- 035 __
- $a (PubMed)36395147
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Vojtechova, Iveta $u National Institute of Mental Health, Klecany, Czech Republic $u Laboratory of Neurophysiology of Memory, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic $1 https://orcid.org/0000000170297936
- 245 10
- $a Infectious origin of Alzheimer's disease: Amyloid beta as a component of brain antimicrobial immunity / $c I. Vojtechova, T. Machacek, Z. Kristofikova, A. Stuchlik, T. Petrasek
- 520 9_
- $a The amyloid cascade hypothesis, focusing on pathological proteins aggregation, has so far failed to uncover the root cause of Alzheimer's disease (AD), or to provide an effective therapy. This traditional paradigm essentially explains a mechanism involved in the development of sporadic AD rather than its cause. The failure of an overwhelming majority of clinical studies (99.6%) demonstrates that a breakthrough in therapy would be difficult if not impossible without understanding the etiology of AD. It becomes more and more apparent that the AD pathology might originate from brain infection. In this review, we discuss a potential role of bacteria, viruses, fungi, and eukaryotic parasites as triggers of AD pathology. We show evidence from the current literature that amyloid beta, traditionally viewed as pathological, actually acts as an antimicrobial peptide, protecting the brain against pathogens. However, in case of a prolonged or excessive activation of a senescent immune system, amyloid beta accumulation and aggregation becomes damaging and supports runaway neurodegenerative processes in AD. This is paralleled by the recent study by Alam and colleagues (2022) who showed that alpha-synuclein, the protein accumulating in synucleinopathies, also plays a critical physiological role in immune reactions and inflammation, showing an unforeseen link between the 2 unrelated classes of neurodegenerative disorders. The multiplication of the amyloid precursor protein gene, recently described by Lee and collegues (2018), and possible reactivation of human endogenous retroviruses by pathogens fits well into the same picture. We discuss these new findings from the viewpoint of the infection hypothesis of AD and offer suggestions for future research.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a amyloidní beta-protein $x metabolismus $7 D016229
- 650 12
- $a Alzheimerova nemoc $x metabolismus $7 D000544
- 650 _2
- $a amyloidový prekurzorový protein beta $x metabolismus $7 D016564
- 650 _2
- $a mozek $x patologie $7 D001921
- 650 12
- $a antiinfekční látky $x metabolismus $7 D000890
- 650 _2
- $a antibakteriální látky $x terapeutické užití $7 D000900
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Machacek, Tomas $u Department of Parasitology, Faculty of Science, Charles University, Prague, Czech Republic
- 700 1_
- $a Kristofikova, Zdenka $u National Institute of Mental Health, Klecany, Czech Republic
- 700 1_
- $a Stuchlik, Ales $u National Institute of Mental Health, Klecany, Czech Republic $u Laboratory of Neurophysiology of Memory, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic
- 700 1_
- $a Petrasek, Tomas $u National Institute of Mental Health, Klecany, Czech Republic $u Laboratory of Neurophysiology of Memory, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic
- 773 0_
- $w MED00008922 $t PLoS pathogens $x 1553-7374 $g Roč. 18, č. 11 (2022), s. e1010929
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36395147 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230120 $b ABA008
- 991 __
- $a 20230131151243 $b ABA008
- 999 __
- $a ok $b bmc $g 1891415 $s 1183975
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2022 $b 18 $c 11 $d e1010929 $e 20221117 $i 1553-7374 $m PLOS pathogens $n PLoS Pathog $x MED00008922
- LZP __
- $a Pubmed-20230120
